Literature DB >> 11811785

IFN-alpha acts on T-cell receptor-triggered human peripheral leukocytes to up-regulate CCR5 expression on CD4+ and CD8+ T cells.

Y F Yang1, M Tomura, M Iwasaki, S Ono, J P Zou, K Uno, G M Shearer, H Fujiwara, T Hamaoka.   

Abstract

Interleukin-12 (IL-12) as well as IL-2 was recently shown to up-regulate CCR5 expression on T-cell receptor (TCR)-triggered human T cells. Because of the functional similarity between interferon-alpha (IFN-alpha) and IL-12, the present study investigated whether IFN-alpha also up-regulates T cell CCR5 expression. CCR5 was marginally detected on T cells from unstimulated human peripheral blood leukocytes (PBLs) and only slightly induced on PBL T cells following stimulation with anti-CD3 plus anti-CD28 monoclonal antibodies (mAbs). When anti-CD3/anti-CD28-triggered PBLs were exposed to IFN-alpha, T cells expressed high levels of CCR5. The levels of CCR5 expression were comparable to those induced by IL-12. However, when purified T cells instead of unfractionated PBL were stimulated with anti-CD3/CD28 and then exposed to IL-12 or IFN-alpha, CCR5 expression was induced by IL-12 but not by IFN-alpha. IFN-alpha was found to act on anti-CD3/anti-CD28-stimulated PBL to promote their IL-12 production. Moreover, addition of anti-IL-12 mAb to IFN-alpha-stimulated cultures of anti-CD3/CD28-pretreated PBL resulted in considerable inhibition of CCR5 expression. Together, these results indicate that IFN-alpha as well as IL-12 up-regulates CCR5 expression on TCR-triggered T cells and that IFN-alpha functions not by acting directly on T cells but via enhancing IL-12 production by PBL.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11811785     DOI: 10.1023/a:1013173610032

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  46 in total

1.  IL-4 and IFN (alpha and gamma) exert opposite regulatory effects on the development of cytolytic potential by Th1 or Th2 human T cell clones.

Authors:  P Parronchi; M De Carli; R Manetti; C Simonelli; S Sampognaro; M P Piccinni; D Macchia; E Maggi; G Del Prete; S Romagnani
Journal:  J Immunol       Date:  1992-11-01       Impact factor: 5.422

Review 2.  Chemokines and T lymphocytes: more than an attraction.

Authors:  S G Ward; K Bacon; J Westwick
Journal:  Immunity       Date:  1998-07       Impact factor: 31.745

3.  CCR5 is characteristic of Th1 lymphocytes.

Authors:  P Loetscher; M Uguccioni; L Bordoli; M Baggiolini; B Moser; C Chizzolini; J M Dayer
Journal:  Nature       Date:  1998-01-22       Impact factor: 49.962

4.  Differential capacities of CD4+, CD8+, and CD4-CD8- T cell subsets to express IL-18 receptor and produce IFN-gamma in response to IL-18.

Authors:  M Tomura; S Maruo; J Mu; X Y Zhou; H J Ahn; T Hamaoka; H Okamura; K Nakanishi; S Clark; M Kurimoto; H Fujiwara
Journal:  J Immunol       Date:  1998-04-15       Impact factor: 5.422

5.  Interferon-alpha/beta inhibition of interleukin 12 and interferon-gamma production in vitro and endogenously during viral infection.

Authors:  L P Cousens; J S Orange; H C Su; C A Biron
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-21       Impact factor: 11.205

Review 6.  Acquisition of lymphokine-producing phenotype by CD4+ T cells.

Authors:  R A Seder; W E Paul
Journal:  Annu Rev Immunol       Date:  1994       Impact factor: 28.527

Review 7.  The molecular biology of leukocyte chemoattractant receptors.

Authors:  P M Murphy
Journal:  Annu Rev Immunol       Date:  1994       Impact factor: 28.527

8.  Chemokine receptors and T cell chemotaxis.

Authors:  C R Mackay
Journal:  J Exp Med       Date:  1996-09-01       Impact factor: 14.307

9.  Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes.

Authors:  M Kobayashi; L Fitz; M Ryan; R M Hewick; S C Clark; S Chan; R Loudon; F Sherman; B Perussia; G Trinchieri
Journal:  J Exp Med       Date:  1989-09-01       Impact factor: 14.307

10.  Stimulatory and inhibitory effects of interleukin (IL)-4 and IL-13 on the production of cytokines by human peripheral blood mononuclear cells: priming for IL-12 and tumor necrosis factor alpha production.

Authors:  A D'Andrea; X Ma; M Aste-Amezaga; C Paganin; G Trinchieri
Journal:  J Exp Med       Date:  1995-02-01       Impact factor: 14.307

View more
  7 in total

1.  Marked differences in CCR5 expression and activation levels in two South African populations.

Authors:  Anabela C P Picton; Sharon Shalekoff; Maria Paximadis; Caroline T Tiemessen
Journal:  Immunology       Date:  2012-08       Impact factor: 7.397

2.  CCR5 promoter haplotypes differentially influence CCR5 expression on natural killer and T cell subsets in ethnically divergent HIV-1 uninfected South African populations.

Authors:  Anabela C P Picton; Maria Paximadis; Caroline T Tiemessen
Journal:  Immunogenetics       Date:  2012-08-15       Impact factor: 2.846

3.  Trafficking of human immunodeficiency virus type 1-specific CD8+ T cells to gut-associated lymphoid tissue during chronic infection.

Authors:  Barbara L Shacklett; Catherine A Cox; Johan K Sandberg; Neil H Stollman; Mark A Jacobson; Douglas F Nixon
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

Review 4.  Role of chemokines and their receptors in viral persistence and liver damage during chronic hepatitis C virus infection.

Authors:  Juan R Larrubia; Selma Benito-Martínez; Miryam Calvino; Eduardo Sanz-de-Villalobos; Trinidad Parra-Cid
Journal:  World J Gastroenterol       Date:  2008-12-21       Impact factor: 5.742

Review 5.  Cytokines and HCV-related disorders.

Authors:  Poupak Fallahi; Clodoveo Ferri; Silvia Martina Ferrari; Alda Corrado; Domenico Sansonno; Alessandro Antonelli
Journal:  Clin Dev Immunol       Date:  2012-05-07

Review 6.  Sympathetic Nerves and Innate Immune System in the Spleen: Implications of Impairment in HIV-1 and Relevant Models.

Authors:  Denise L Bellinger; Dianne Lorton
Journal:  Cells       Date:  2022-02-15       Impact factor: 6.600

7.  Clinical significance of the CCR5delta32 allele in hepatitis C.

Authors:  Isabelle Morard; Sophie Clément; Alexandra Calmy; Alessandra Mangia; Andrea Cerny; Andrea De Gottardi; Meri Gorgievski; Markus Heim; Raffaele Malinverni; Darius Moradpour; Beat Müllhaupt; David Semela; Stéphanie Pascarella; Pierre-Yves Bochud; Franco Negro
Journal:  PLoS One       Date:  2014-09-05       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.